Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis

scientific article published in July 2010

Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/02841851003782059
P698PubMed publication ID20429756

P50authorJana RydlandQ114422036
Tone F. BathenQ61104171
Kjell Arne KvistadQ64213708
Ingrid Susann GribbestadQ65706743
Steinar LundgrenQ65706815
Pål Erik GoaQ92895190
Mariann G HeldahlQ114422031
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
P304page(s)604-612
P577publication date2010-07-01
P1433published inActa RadiologicaQ4033350
P1476titlePrognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis
P478volume51

Reverse relations

cites work (P2860)
Q37721539Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer
Q39547119Association between survival in patients with primary invasive breast cancer and computer aided MRI.
Q39262277Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis
Q44491240Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy
Q48265826Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary results.
Q61809423Contrast-enhanced ultrasound for evaluating the pathologic response of breast cancer to neoadjuvant chemotherapy: A meta-analysis
Q30460977Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy.
Q37093041DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings
Q37292720Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer
Q35926256Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes
Q38752236Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer.
Q34016780In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response
Q36853113MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers
Q53213556Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?
Q35866905Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy
Q86054997Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators

Search more.